Chester J. Joyner
Assistant Professor
B cell and plasma cell biology | Plasmodium vivax hypnozoites | Molecular parasitology | Malarial anemia pathogenesis | Malaria | Immunology and vaccines.
Karen A. Norris
GRA Eminent Scholar in Immunology and Translational Biomedicine, Professor
Immunology and infectious diseases | Vaccine and immunotherapeutic treatments for fungal infections | Respiratory syncytial virus (RSV) – maternal/fetal immunity | HIV associated comorbidities | Pulmonary arterial hypertension (PAH); Immune-mediated mechanisms of pathogenesis | Immunity in high-risk populations
Whitney Rabacal
Assistant Research Scientist
Vaccination strategies for the prevention of Pneumocystis pneumonia (PCP) and COPD | Immune aging | Immunopathogenesis of HIV-comorbidities
Ted M. Ross
Part-Time Professor
Development of Broadly Reactive Vaccines using computationally optimized broadly reactive antigen (COBRA) modeling. Influenza, HIV, Dengue | Modeling Immunity to Biodefense agents and influenza | Influenza VLP-based vaccines for seasonal and pandemic influenza | Pathogenicity/Genomic Modeling of influenza infection in adult and elderly ferrets, and humans | Evaluation of human clinical samples following influenza vaccination | Development of tetravalent Dengue VLP-based vaccines | Development of VLPs for RVFV and CCHFV | Multiclade Consensus Env VLP AIDS vaccine | Using Consensus ENV Sequences to broaden immunity | Using C3d adjuvants in a DNA vaccine to enhance the immunogenicity to HIV/SIV, RVFV, Dengue, West Nile, Chikungunya virus envelopes | Development and testing pandemic H5N1, H1N1, H7N9 subtypes
S. Mark Tompkins
Director of the Center for Vaccines & Immunology, Georgia Athletic Association Distinguished Professor in Virology and Immunology, Professor
Experimental models of virus-pathogen-host interactions | Viral and bacterial respiratory co-infections; synergies and mechanisms of disease | Pathogen- and vaccine- elicited immunity and immunopathology | Risk assessment of emerging pathogens, focused on zoonotic influenza viruses | Development of novel vaccine and adjuvant platforms against infectious diseases
